Developers of residential dual occupancy properties in Sydney, Australia. Specialising in full project management including funding, acquisition, council approvals, construction and sale. Tridas are also referral partners to leading residential and commercial lenders.

Antibody depletion technology combined with enrichment technology using enteric commensal bacteria, and exogenous dietary bacteria, using selected probiotics, prebiotics, active ingredients, excipients, and their beneficial metabolites.

Ouft manages the corporate interests of companies with multiple entities by consolidating their operation while partnering and connecting business owners to opportunities and markets.

Purchases residential development sites in Sydney’s most exclusive suburbs for the purpose of constructing either an attached or detached dual occupancy. Each development is based on extensive feasibilities against strict guidelines set by Pireh Group, ensuring every project is profitable in any market.

A growing portfolio of investments with interests in residential / commercial properties, disruptive technologies and innovative companies.